Pharmacokinetics and safety of coformulated bictegravir emtricitabine and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV a phase 23 openlabel singlearm study

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By